NCT04659226: MicroRNA Profile and Erenumab Treatment
- State
- Completed
- Phase
- No phase
- People
- 40 taking part
- Started
- 1 Jul 2021
- Primary completion
- 31 Dec 2022
- Arms
- Episodic or chronic migraine
- Results
- None posted
- 9 Dec 2020: Trial registered
- 1 Jul 2021: Trial started
- 30 Apr 2023: Trial completed